Management of patients with chronic lymphocytic leukemia during the SARS-CoV-2 pandemic

In conclusion, therapeutic decisions must be personalized to each patient with CLL and each at risk patient must be quarantined during the SARS-CoV-2 pandemic to reduce their risk of contraction.PMID:34295383 | PMC:PMC8273855 | DOI:10.3892/ol.2021.12897

Source: Oncology Letters - July 23, 2021 Category: Cancer & Oncology Authors: Romeo Gabriel Mihaila Source Type: research